Glucagon News and Research

RSS

Researchers assess Alzheimer's disease risk and anti-diabetic drugs

In a new study, researchers assessed the genetic variation among targets of Alzheimer's disease risk and anti-diabetic drugs.

3 Aug 2022

Study highlights the urgent need to evaluate deficiencies in the energy balance model for the prevention and treatment of obesity

In a new study, researchers highlighted the urgent need to substitute highly processed carbohydrates with minimally processed carbohydrates or healthy fats to cease the obesity pandemic that continues relentlessly.

2 Aug 2022

Diabetes patients on Medicare Advantage plans less likely to be prescribed newer, more expensive medicines

While patients with diabetes on Medicare Advantage plans are more likely to receive preventive treatments, they were less likely to be prescribed newer, more expensive medications and were more likely to have higher blood pressure and worse blood glucose control than patients on Medicare Fee-For-Service plans, according to a new study led by a University of Pittsburgh School of Medicine physician-scientist.

7 Jul 2022

Scientists explore brainstem circuits to find nausea intervention strategies

In a new study, researchers uncovered the organization of nausea-associated brainstem circuits to show that selectively blocking the excitatory neurons responsive to nausea-promoting growth/differentiation factor 15 suppresses nausea-related behaviors.

20 Jun 2022

Machine learning and proteomics predict cardiovascular risk more accurately

An innovative proteomics-based model that predicts the risk of cardiovascular events with higher accuracy than current clinical models.

10 Apr 2022

Increased levels of a microRNA in type 2 diabetes have negative effect on insulin secretion

Researchers at Lund University have discovered increased levels of of a microRNA in type 2 diabetes, which has a negative effect on insulin secretion.

29 Mar 2022

Diabetes and the mTOR pathway in COVID-19 patients

A new study discusses the possible etiopathogenetic mechanisms associated with diabetes that could enhance the severity of COVID-19.

6 Mar 2022

Study explores the impact of COVID-19 on pancreatic cells

New study findings showed that SARS-CoV-2 caused a productive yet restricted infection of pancreatic islet cells and an insignificant inflammatory response.

23 Feb 2022

Researchers discover why patients suffering with hypertension also have diabetes

The long-standing enigma of why so many patients suffering with high blood pressure (known as hypertension) also have diabetes (high blood sugar) has finally been cracked by an international team led by the universities of Bristol, UK, and Auckland, New Zealand.

1 Feb 2022

DPP4 protein: The connection between severe COVID-19 and diabetes

Researchers explore the relationship between DPP4 and diabetes targets in the management of COVID-19.

17 Jan 2022

Fewer than 1 in 5 U.S. adults with Type 2 diabetes meet targets to reduce heart disease risk

Fewer than 1 in 5 adults with Type 2 diabetes in the U.S. are meeting targets to reduce heart disease risk. Fortunately, available therapies can help when combined with new approaches that address social determinants of health and other barriers to care, according to a new American Heart Association scientific statement published today in the Association's flagship journal Circulation.

10 Jan 2022

Research finds a new way for the treatment of hypoglycemia

New research has taken an important step towards the goal for a treatment for the common diabetes complication hypoglycemia, or low blood sugar.

17 Dec 2021

New study shows inequities in the use of heart disease-protective diabetes drug

A medication typically used for treating diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RA), could also be used to prevent cardiovascular disease and major cardiovascular events, but a new study showed inequities in its use based on race, ethnicity, and socioeconomic status.

17 Dec 2021

Drug treatment decreases risk for severe COVID-19 outcomes in patients with Type 2 diabetes

A type of drug already used to treat obesity and Type 2 diabetes, when taken six months prior to the diagnosis of COVID-19, was associated with a decreased risk of hospitalization, respiratory complications and death in COVID-19 patients with Type 2 diabetes, according to researchers at Penn State College of Medicine.

27 Sep 2021

Experimental device offers glycemic control to hyperinsulinism patients after pancreatectomy

Researchers at Children's Hospital of Philadelphia have demonstrated that an experimental device can improve blood sugar control in patients who developed diabetes after their pancreas was removed to treat their hyperinsulinism, a genetic disease in which the pancreas produces too much insulin.

13 Sep 2021

Glucagon News and Research

Researchers assess Alzheimer's disease risk and anti-diabetic drugs

Study highlights the urgent need to evaluate deficiencies in the energy balance model for the prevention and treatment of obesity

Diabetes patients on Medicare Advantage plans less likely to be prescribed newer, more expensive medicines

Scientists explore brainstem circuits to find nausea intervention strategies

Machine learning and proteomics predict cardiovascular risk more accurately

Increased levels of a microRNA in type 2 diabetes have negative effect on insulin secretion

Diabetes and the mTOR pathway in COVID-19 patients

Study explores the impact of COVID-19 on pancreatic cells

Researchers discover why patients suffering with hypertension also have diabetes

DPP4 protein: The connection between severe COVID-19 and diabetes

Fewer than 1 in 5 U.S. adults with Type 2 diabetes meet targets to reduce heart disease risk

Research finds a new way for the treatment of hypoglycemia

New study shows inequities in the use of heart disease-protective diabetes drug

Drug treatment decreases risk for severe COVID-19 outcomes in patients with Type 2 diabetes

Experimental device offers glycemic control to hyperinsulinism patients after pancreatectomy

Carbohydrate-insulin model can better explain obesity and weight gain

UC San Diego researchers receive $6 million NIH grant to study insulin-producing cells

Fruit fly provides insight into controlling carbs and fat

Novel method for glucagon delivery to help individuals living with Type 1 diabetes

Research shows how circadian control of glucose production is disrupted during lung cancer progression

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News